CE-Ventures, the corporate venture capital arm of Crescent Enterprises, on Tuesday announced that its portfolio company CrossBridge Bio has entered into a definitive agreement to be acquired by US pharmaceutical major Eli Lilly and Company.
XCath, a medical device company dedicated to pioneering neuro-endovascular surgical robotics, and UAE-based Crescent Enterprises, the founding and largest shareholder of XCath, have announced the successful first-in-human use of XCath’s EVR robotic system to treat three patients with complex brain aneurysms.
CE-Invests, the strategic investments platform of Crescent Enterprises, has announced plans to deploy AED1 billion ($272.2 million) over the next three years in high‑growth markets across India, Southeast Asia, and the GCC.
Crescent Enterprises has reaffirmed its commitment to advancing sustainable, inclusive, and innovation-led urban growth as a Premier Partner of the 2025 Asia Pacific Cities Summit (APCS) and Mayors’ Forum, hosted this week at Expo City Dubai.
CE-Ventures, the corporate venture capital platform of Crescent Enterprises, has announced the successful exit of its equity stake in Transcorp, a UAE-based logistics and fulfilment company, via a strategic sale to Elite Co, a leading regional operator backed by Green Dome Investments.
Crescent Enterprises, a multinational company based in the UAE with strategic investments across sectors, has announced an investment programme of AED250 million ($68.07 million) to scale CE-Creates, its venture-building platform.
